Cargando…

Management strategies and cost effectiveness in the prevention of cervical cancer

This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given....

Descripción completa

Detalles Bibliográficos
Autor principal: Prasad, Smita R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169989/
https://www.ncbi.nlm.nih.gov/pubmed/21935303
_version_ 1782211563065704448
author Prasad, Smita R
author_facet Prasad, Smita R
author_sort Prasad, Smita R
collection PubMed
description This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism.
format Online
Article
Text
id pubmed-3169989
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31699892011-09-20 Management strategies and cost effectiveness in the prevention of cervical cancer Prasad, Smita R Clinicoecon Outcomes Res Review This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism. Dove Medical Press 2009-06-05 /pmc/articles/PMC3169989/ /pubmed/21935303 Text en © 2009 Prasad, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Prasad, Smita R
Management strategies and cost effectiveness in the prevention of cervical cancer
title Management strategies and cost effectiveness in the prevention of cervical cancer
title_full Management strategies and cost effectiveness in the prevention of cervical cancer
title_fullStr Management strategies and cost effectiveness in the prevention of cervical cancer
title_full_unstemmed Management strategies and cost effectiveness in the prevention of cervical cancer
title_short Management strategies and cost effectiveness in the prevention of cervical cancer
title_sort management strategies and cost effectiveness in the prevention of cervical cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169989/
https://www.ncbi.nlm.nih.gov/pubmed/21935303
work_keys_str_mv AT prasadsmitar managementstrategiesandcosteffectivenessinthepreventionofcervicalcancer